Can multi-criteria decision analysis be implemented into real world drug decision-making processes? A Canadian provincial experience

7 August 2020 - This paper describes the implementation of multi-criteria decision analysis into a Canadian public drug reimbursement decision-making process, ...

Read more →

SMC - August 2020 decisions

10 August 2020 - The Scottish Medicines Consortium has today published advice accepting neratinib (Nerlynx) for the treatment of breast ...

Read more →

Coming of age: emerging health preference research based on established scientific standards

10 August 2020 - Value in Health themed section enhances the scientific respectability and relevance of health preference research. ...

Read more →

ICER to assess treatments for lupus nephritis

10 August 2020 - Report will be subject of New England CEPAC meeting in March 2021; Open Input now being accepted ...

Read more →

Rheumatoid arthritis drug Rinvoq gets insurance benefit

7 August 2020 - AbbVie Korea’s rheumatoid arthritis treatment Rinvoq (upadacitinib) has obtained the national health insurance benefit. ...

Read more →

NICE supports use of new medicine for patients with malignant disease

5 August 2020 - Treosulphan is used as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation. ...

Read more →

Darolutamide in prostate cancer: indication of considerable added benefit

3 August 2020 - Advantages in overall survival, symptoms and health-related quality of life. ...

Read more →

Principles for deliberative processes in health technology assessment

4 August 2020 - Deliberative processes are a well-established part of health technology assessment programs in a number of high- and ...

Read more →

NICE publishes draft guidance on the use of a topical gel by patients with a rare cancer

5 August 2020 - The Department of Health and Social Care has asked NICE to produce guidance on using chlormethine gel ...

Read more →

ISPOR announces Virtual ISPOR Asia Pacific 2020

3 August 2020 - ISPOR—The Professional Society for Health Economics and Outcomes Research announced its Virtual ISPOR Asia Pacific 2020 ...

Read more →

NICE recommends Bavencio (avelumab) in combination with axitinib for first-line treatment of adult patients with advanced renal cell carcinoma

31 July 2020 - This is the first combination of an immunotherapy with a targeted antiangiogenic therapy to be recommended ...

Read more →

NICE rejects NHS funding for Kyowa Kirin's Poteligeo

30 July 2020 - NICE is not recommending NHS funding for Kyowa Kirin's Poteligeo (mogamulizumab) as a treatment for mycosis ...

Read more →

CADTH publishes final recommendation for a new combination product for HIV infection

24 July 2020 - Cabenuva (cabotegravir and rilpivirine extended release injectable suspensions) is indicated as a complete regimen for the treatment ...

Read more →

CADTH posts final recommendation for Aimovig

26 July 2020 - Final recommendation informed by input from Migraine Canada and Migraine Quebec. ...

Read more →

Gilead and Galapagos announce positive European CHMP opinion for Jyseleca (filgotinib) for the treatment of adults with moderate to severe rheumatoid arthritis

24 June 2020 - Clinical development program of filgotinib demonstrated durable efficacy balanced with a consistent safety profile in rheumatoid ...

Read more →